Lupin Launches Generic Intermezzo

Lupin announced the launch of Zolpidem Sublingual Tablets, the generic version of Purdue's Intermezzo.

Intermezzo is an imidazopyridine hypnotic indicated for use as needed for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep. It interacts with a GABA-BZ complex and shares some of the pharmacological properties of the benzodiazepines. In contrast to the benzodiazepines, which non-selectively bind to and activate all BZ receptor subtypes, zolpidem in vitro binds the BZ1 receptor preferentially with a high affinity ratio of the alpha1/alpha5 subunits. 

Zolpidem Sublingual Tablets are available in 1.75mg and 3.5mg strengths.  

For more information call (800) 399-2561 or visit